Effects of anesthetics on the function of orexin-1 receptors expressed in Xenopus oocytes

Pharmacology

Volumn 79, Issue 4, 2007, Pages 236-242

  Minami, Kouichiro ^a   Uezono, Yasuhito ^b   Sakurai, Takeshi ^c   Horishita, Takafumi ^d   Shiraishi, Munehiro ^d   Ueta, Yoichi ^d  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Anesthetics; Orexin A; Orexin 1 receptor

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; ALCOHOL; ANESTHETIC AGENT; CALCIUM; CHLORINE; ENFLURANE; HALOTHANE; ISOFLURANE; KETAMINE; OREXIN 1 RECEPTOR; OREXIN A; PENTOBARBITAL;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; FEMALE; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; XENOPUS;

ANESTHETICS, INHALATION; ANESTHETICS, INTRAVENOUS; ANIMALS; CALCIUM; CHLORIDE CHANNELS; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOL; FEMALE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NEUROPEPTIDES; OOCYTES; PATCH-CLAMP TECHNIQUES; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE; XENOPUS LAEVIS;

EID: 34249788434     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000101713     Document Type: Article

References (30)

1. Voisin T, Rouet-Benzineb P, Reuter N, Laburthe M: Orexins and their receptors: structural aspects and role in peripheral tissues. Cell Mol Life Sci 2003;60:72-87.
2. Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, Sutcliffe JG, Kilduff TS: Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 1998;18:9996-10015.
3. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, Kozlowski GP, Wilson S, Arch JR, Buckingham RE, Haynes AC, Carr SA, Annan RS, McNulty DE, Liu WS, Terrett JA, Elshourbagy NA, Bergsma DJ, Yanagisawa M: Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998;92:573-585.
4. Franks NP, Lieb WR: Molecular and cellular mechanisms of general anaesthesia. Nature 1994;367:607-614.
5. Harris RA, Mihic SJ, Dildy-Mayfield JE, Machu TK: Actions of anesthetics on ligand-gated ion channels: role of receptor subunit composition. FASEB J 1995;9:1454-1462.
6. Minami K, Vanderah TW, Minami M, Harris RA: Inhibitory effects of anesthetics and ethanol on muscarinic receptors expressed in Xenopus oocytes. Eur J Pharmacol 1997;339:237-244.
7. Minami K, Minami M, Harris RA: Inhibition of 5-hydroxytryptamine type 2A receptor-induced currents by n-alcohols and anesthetics. J Pharmacol Exp Ther 1997;281:1136-1143.
8. Minami K, Shiraishi M, Uezono Y, Uezono S, Shigematsu A: The inhibitory effects of anesthetics and ethanol on substance P receptors expressed in Xenopus oocytes. Anesth Analg 2002;94:79-83.
9. Minami K, Gereau RW 4th, Minami M, Heinemann SF, Harris RA: Effects of ethanol and anesthetics on type 1 and 5 metabotropic glutamate receptors expressed in Xenopus laevis oocytes. Mol Pharmacol 1998;53:148-156.
10. Minami K, Uezono Y: Gq protein-coupled receptors as targets for anesthetics. Curr Pharm Design 2006;12:1931-1937.
11. Xi MC, Fung SJ, Yamuy J, Morales FR, Chase MH: Induction of active (REM) sleep and motor inhibition by hypocretin in the nucleus pontis oralis of the cat. J Neurophysiol 2002;87:2880-2888.
12. Bingham S, Davey PT, Babbs AJ, Irving EA, Sammons MJ, Wyles M, Jeffrey P, Cutler L, Riba I, Johns A, Porter RA, Upton N, Hunter AJ, Parsons AA: Orexin-A, an hypothalamic peptide with analgesic properties. Pain 2001;92:81-90.
13. Hervieu GJ, Cluderay JE, Harrison DC, Roberts JC, Leslie RA: Gene expression and protein distribution of the orexin-1 receptor in the rats brain and spinal cord. Neuroscience 2001;103:777-797.
14. Yamamoto T, Saito O, Shono K, Hirasawa S: Activation of spinal orexin-1 receptor produces anti-allodynic effect in the rat carrageenan test. Eur J Pharmacol 2003;481:175-180.
15. Dildy-Mayfield JE, Mihic SJ, Liu Y, Deitrich RA, Harris RA: Actions of long chain alcohols on GABAA and glutamate receptors: relation to in vivo effects. Br J Pharmacol 1996;118:378-384.
16. Mihic SJ, McQuilkin SJ, Eger EI 2nd, Ionescu P, Harris RA: Potentiation of gamma-aminobutyric acid type A receptor-mediated chloride currents by novel halogenated compounds correlates with their abilities to induce general anesthesia. Mol Pharmacol 1994;46:851-857.
17. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, Loriolle F, Duhamell L, Charon D, Kirilovsky J: The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 1991;266:15771-15781.
18. Holmqvist T, Akerman KE, Kukkonen JP: High specificity of human orexin receptors for orexins over neuropeptide Y and other neuropeptides. Neurosci Lett 2001;305:177-180.
19. 2+ influx pathway necessary for coupling to phospholipase C. J Biol Chem 2000;275:30806-30812.
20. Okumura T, Takeuchi S, Motomura W, Yamada H, Egashira Si S, Asahi S, Kanatani A, Ihara M, Kohgo Y: Requirement of intact disulfide bonds in orexin-A-induced stimulation of gastric acid secretion that is mediated by OX1 receptor activation. Biochem Biophys Res Commun 2001;280:976-981.
21. Smart D, Sabido-David C, Brough SJ, Jewitt F, Johns A, Porter RA, Jerman JC: SB-334867-A: the first selective orexin-1 receptor antagonist. Br J Pharmacol 2001;132:1179-1182.
22. Franks NP, Lieb WR: Selective actions of volatile general anaesthetics at molecular and cellular levels. Br J Anaesth 1993;71:65-76.
23. Wieber J, Gugler R, Hengstmann JH, Dengler HJ: Pharmacokinetics of ketamine in man. Anaesthesist 1975;24:260-263.
24. Idvall J, Ahlgren I, Aronsen KR, Stenberg P: Ketamine infusions: pharmacokinetics and clinical effects. Br J Anaesth 1979;51:1167-1173.
25. Nguyen KT, Stephens DP, McLeish MJ, Crankshaw DP, Morgan DJ: Pharmacokinetics of thiopental and pentobarbital enantiomers after intravenous administration of racemic thiopental. Anesth Analg 1996;83:552-558.
26. Kushikata T, Hirota K, Yoshida H, Kudo M, Lambert DG, Smart D, Jerman JC, Matsuki A: Orexinergic neurons and barbiturate anesthesia. Neuroscience 2003;121:855-863.
27. Lin L, Faraco J, Li R, Kadotani H, Rogers W, Lin X, Qiu X, de Jong PJ, Nishino S, Mignot E: The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 1999;98:365-376.
28. Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee C, Richardson JA, Williams SC, Xiong Y, Kisanuki Y, Fitch TE, Nakazato M, Hammer RE, Saper CB, Yanagisawa M: Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 1999;98:437-451.
29. Saper CB, Chou TC, Scammell TE: The sleep switch: hypothalamic control of sleep and wakefulness. Trends Neurosci 2001;24:726-731.
30. Yasuda Y, Takeda A, Fukuda S, Suzuki H, Ishimoto M, Mori Y, Eguchi H, Saitoh R, Fujihara H, Honda K, Higuchi T: Orexin A elicits arousal electroencephalography without sympathetic cardiovascular activation in isoflurane-anesthetized rats. Anesth Analg 2003;97:1663-1666.